Biotech sector has been on the boom since 2012, the uptrend seems continuing
Quarterly chart wise, it has shown some euphoric state.
We have a serious bearish RSI divergence shown, breaking of the uptrend line in RSI has serious
long-term consequence and detrimental to further uptrend.